Table of Contents:
Next Steps – Phase 3 Consultations
Public consultations are open from 28 March to 23 May 2018. The release of the Preliminary Report marks the start of this consultation process.
Through the consultation processes to date, the Review has heard a diverse range of stakeholder views. These have led to the development of Review findings, which identify aspects of the Scheme that:
- have operated successfully since its establishment and which should be maintained; and
- may assist to futureproof and modernise the Scheme.
Stakeholders are invited to provide their feedback to inform the findings as outlined in the Preliminary Report. In particular, the Review is seeking comment to refine the findings, including whether there are any major considerations that have been missed.
Stakeholders are invited to provide feedback through an online submission process on or before 23 May 2018.
The intergovernmental Gene Technology Agreement requires that reviews of the National Gene Technology Scheme (the Scheme) are undertaken regularly. The first review was held in 2006, with a second ‘lighter touch’ review held in 2011.
The ministerial committee with responsibility for oversight of the Scheme, the Legislative and Governance Forum on Gene Technology (LGFGT), announced the current review in July 2017.
This Review will ensure the scheme remains effective, agile and supports innovation into the future, and continues to meet the objective of the Act which is to:
"to protect the health and safety of people and to protect the environment by identifying risks posed by or as a result of gene technology, and by managing those risks through regulating certain dealings with GMOs”
Consultation is currently underway and there are a number of opportunities for stakeholders to participate in, and contribute to, a final report to be agreed and implemented by all governments through the LGFGT.
The consultation has been organised in three key phases aimed at identifying key issues for consideration, collaboratively exploring policy solutions to these issues, and finally providing an opportunity to comment on the findings:
Phase One - Written Submissions - (Now Closed)
- 25 July – 29 September 2017 (10 weeks): gained an understanding of key issues to be addressed through the review by seeking input from stakeholders (through a written submission process), and examining input into other reports and reviews (including the Productivity Commission report on Regulation of Australian Agriculture and the House of Representatives Smart farming – Inquiry into agricultural innovation).
Phase Two - Explore options and possible policy solutions (Now Closed)
- Open consultation 6 November – 15 December 2017: using the input from Phase one, the Review engaged collaboratively with stakeholders (through issues papers, workshops, forums, surveys, targeted meetings, market research and written submissions ) to explore options and develop solutions to the issues captured.
Phase Three - Preliminary Report (Now Open)
- Open consultation (28 March 2018): taking into account Phase One and Two considerations, present findings for stakeholder comment - feedback can be provided through the online submission process.
Expert Advisory Panel Appointment
The Legislative and Governance Forum on Gene Technology (LGFGT) has appointed technical advisors, Ms Claire Noone, Prof Ian Small, Prof David Tscharke and Dr Mark Tizard, to the 2017 Gene Technology Scheme Review Expert Advisory Panel (EAP).
As outlined in their biographies, these individuals bring specific expertise across key areas including environment, biology, ethics, law, gene technology and regulation.
In conducting their work, EAP members are required to provide technical advice into the review process, assist in understanding the issues and development of sound solutions.
On 28 November and 6 December 2017, two scheduled webinars provided a broad range of stakeholders the opportunity to participate in online discussion, and capture potential solutions to the issues identified within Phase 1 consultation.
Throughout the webinars, stakeholders interacted with members of the Expert Advisory Panel (EAP) through the ‘live chat’ functionality. The objective was to provide opportunities for participants to clarify their understanding of the questions posed in the consultation paper, prior to submitting their feedback. The questions and answers provided by EAP members will be uploaded to this webpage shortly.
Should you have missed the opportunity to participate, a recording of the webinar is available for your viewing. Please note that live Q&A/interaction with EAP members is no longer available.
The Third Review of the Gene Technology Scheme - Preliminary Report
Submissions to Consultations
Terms of Reference of the Review
The Joint Communique from the Legislative and Governance Forum on Gene Technology (July 2017) outlines the Review.
Please email the Review Secretariat or telephone 02 6289 2033 should you have any questions on the process.
To ensure you’re kept up to date on the Review progress, please subscribe by clicking on the subscribe button.